The market for Tissue Engineering Market is expected to reach US$ XX Bn in 2022
Tissue engineering is the study of the growth of new connective tissues, or organs, from cells and a collagenous scaffold to produce a fully functional organ for implantation back into the donor host. This technique allows the organs to be grown from implantation and is therefore free from immunological rejection. Tissue engineering is primarily used for the treatment of burns and accident wounds, for cosmetic surgeries, in correcting birth defects, in wound care, in orthopedics, and in neurology, amongst others. Advancements in cell culture technology have encouraged the adaptation of tissue engineering in the healthcare industry. Moreover, the use of animal testing models has raised various ethical issues, and hence, the demand for tissue engineered human equivalents is growing at a rapid rate.
The tissue engineering market is expected to witness rapid growth due to its rapid diversification and growth as it allows circumvention of the problem of organ shortage. Furthermore, the development in biochemistry, biomaterials, molecular medicine, genetics, nanotechnology, and biomedical engineering would further assist the market during the forecast period of 2016–2022. According to market experts, the increasing applications of tissue engineering in the neurological and dental segments would contribute to the growth of the tissue engineering market in the future. Favorable policies of the governments in relation to tissue engineering will also add incremental opportunity to exploit this market.
Global Tissue Engineering Market Revenue (US$ Mn), By Applications, 2016–2022.
Global Tissue Engineering Market Revenue (US$ Mn), By Geography, 2016-2022
Key players identified for the tissue engineering market include:
Medtronic plc, Acell, Inc., Zimmer Biomet, Athersys, Inc., Organogenesis, Inc., Stryker Corporation, and ReproCell, Inc.
The market for Tissue Engineering Market is expected to reach US$ XX Bn in 2022
The Tissue Engineering Market is expected to see significant CAGR growth over the coming years, at XX.
The report is forecasted from 2016-2022.
The base year of this report is 2015.
Medtronic plc, Acell, Inc., Zimmer Biomet, Athersys, Inc., Organogenesis, Inc., Stryker Corporation, and ReproCell, Inc. are some of the major players in the global market.